Heart Failure POC And LOC Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Test Type (Proteomic testing, Metabolomic testing, Genomic testing), By Technology (Microfluidics, Array-based systems, Others), By End Use (Clinics, Hospitals, Home, Assisted living healthcare facilities, Laboratory, Others), By Region, and By Competition
Published Date: November - 2024 | Publisher: MIR | No of Pages: 320 | Industry: Healthcare | Format: Report available in PDF / Excel Format
View Details Buy Now 2890 Download Sample Ask for Discount Request CustomizationHeart Failure POC And LOC Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Test Type (Proteomic testing, Metabolomic testing, Genomic testing), By Technology (Microfluidics, Array-based systems, Others), By End Use (Clinics, Hospitals, Home, Assisted living healthcare facilities, Laboratory, Others), By Region, and By Competition
| Forecast Period | 2024-2028 |
| Market Size (2022) | USD 81.72 million |
| CAGR (2023-2028) | 16.66% |
| Fastest Growing Segment | Proteomic Testing |
| Largest Market | North America |
Market Overview
Global Heart Failure POC And LOC Devices Market has valued at USD 81.72 million in 2022 and is anticipated to project impressive growth in the forecast period with a CAGR of 16.66% through 2028. The Global Heart Failure POC and LOC Devices Market refers to a rapidly evolving sector within the healthcare industry that focuses on the development and deployment of innovative diagnostic and monitoring devices specifically designed for heart failure patients. These devices aim to provide more efficient, cost-effective, and patient-friendly solutions for the detection, management, and treatment of heart failure.
Key Market Drivers
Rising Prevalence of Heart Failure
Heart failure is a pervasive and chronic cardiovascular condition, affecting millions of people worldwide. With an aging population, sedentary lifestyles, and an increasing prevalence of risk factors such as obesity and diabetes, the incidence of heart failure is on the rise. However, this health crisis has given rise to an opportunity for innovation in healthcare. The Global Heart Failure Point of Care (POC) and Lab on a Chip (LOC) Devices Market is experiencing remarkable growth due to the escalating prevalence of heart failure.
Heart failure is a global health epidemic, with a prevalence that continues to climb. According to the American Heart Association, over 6 million adults in the United States alone live with heart failure, and it is projected that this number will further increase in the coming years. The situation is similar in many other countries.
The increasing prevalence of heart failure necessitates more efficient diagnostic tools. POC and LOC devices are designed to provide rapid and accurate diagnostics, allowing healthcare professionals to identify heart failure quickly and accurately. With the demand for early diagnosis and intervention, these devices have a pivotal role to play.
Once diagnosed, heart failure patients require ongoing management to maintain their health and prevent complications. POC and LOC devices are not limited to diagnosis; they also offer convenient and timely monitoring solutions. These devices empower both healthcare providers and patients to manage the condition effectively.
Heart failure is associated with significant healthcare costs, including hospitalizations and emergency room visits. POC and LOC devices offer a cost-effective alternative by reducing the need for these costly interventions. Early detection and management can prevent complications and lower healthcare expenditure.
Modern healthcare is increasingly adopting a patient-centric approach. POC and LOC devices fit seamlessly into this model by enabling patients to take a more active role in their health management. With real-time data at their fingertips, patients can make informed decisions and communicate effectively with their healthcare providers.
The rise of telemedicine and remote healthcare monitoring has been further accelerated by the COVID-19 pandemic. POC and LOC devices are integral to this trend. They enable remote monitoring of patients, reducing the need for in-person visits, particularly for those with limited mobility or living in remote areas.
Remote Monitoring Solutions
Heart failure, a prevalent and chronic cardiovascular condition, poses a significant healthcare challenge worldwide. The escalating prevalence of heart failure and the need for effective management have led to a surge in innovation within the healthcare industry. One key driver of growth in the Global Heart Failure Point of Care (POC) and Lab on a Chip (LOC) Devices Market is the integration of remote monitoring solutions.
The incidence of heart failure is on the rise, primarily due to aging populations, unhealthy lifestyles, and an increase in risk factors such as obesity and diabetes. As more people are diagnosed with heart failure, the demand for efficient management solutions is increasing.
POC and LOC devices are at the forefront of diagnosing heart failure, allowing healthcare professionals to swiftly and accurately identify the condition. Early detection and intervention are critical in managing heart failure effectively and reducing hospitalization rates.
Remote monitoring solutions are pivotal in providing ongoing care for heart failure patients. These solutions extend beyond the initial diagnosis and allow healthcare providers to remotely monitor patients' vital signs, symptoms, and medication compliance.
Heart failure patients often experience readmissions to hospitals due to disease exacerbations. Remote monitoring allows healthcare providers to detect warning signs early, enabling timely interventions and reducing the need for costly and burdensome hospitalizations.
Remote monitoring empowers patients to take control of their health. With real-time data accessible through their devices, patients can actively engage in their treatment plans, making informed decisions, adhering to medications, and making lifestyle adjustments.
Remote monitoring eliminates the need for frequent in-person visits, making the management of heart failure more convenient for patients. This not only improves their quality of life but also enhances treatment adherence.
The rise of telemedicine, accelerated by the COVID-19 pandemic, has significantly contributed to the growth of remote monitoring solutions. POC and LOC devices can be seamlessly integrated into telemedicine platforms, facilitating remote consultations and monitoring for heart failure patients.
Patient-Centered Care
Heart failure, a widespread and debilitating cardiovascular condition, poses a formidable challenge to healthcare systems worldwide. The increasing prevalence of heart failure and a growing emphasis on improving patient outcomes have propelled innovations in the healthcare sector. One of the key drivers behind the growth of the Global Heart Failure Point of Care (POC) and Lab on a Chip (LOC) Devices Market is the adoption of a patient-centered care approach.
Heart failure is becoming increasingly prevalent due to aging populations, unhealthy lifestyles, and the rise of risk factors such as obesity and diabetes. As the number of heart failure patients continues to grow, there is a pressing need for innovative and patient-centric solutions.
Patient-centered care places the patient at the heart of healthcare decision-making. It emphasizes the importance of individual preferences, active patient involvement, and tailored healthcare experiences.
POC and LOC devices play a pivotal role in patient-centered care by putting the power of healthcare into the hands of patients. Patients can actively participate in their health management, leading to better adherence to treatment plans and lifestyle modifications.
In a patient-centered approach, patients are encouraged to actively engage in their treatment decisions. POC and LOC devices provide healthcare providers with accurate and timely data, enabling shared decision-making that is more in line with the patient's preferences and needs.
The ability to monitor vital signs and health parameters remotely reduces the need for frequent in-person visits and hospitalizations. This not only eases the patient's burden but also alleviates the strain on healthcare systems.
Patient-centered care, made possible through POC and LOC devices, improves the patient's overall quality of life. It allows for more personalized and less disruptive healthcare experiences, ultimately leading to greater well-being.
Global Awareness
Heart failure, a chronic and debilitating cardiovascular condition, has become a significant global health concern. The rising prevalence of heart failure, combined with an increasing awareness of the need for better diagnostics and management, is driving innovation in the healthcare sector. One of the pivotal factors contributing to the growth of the Global Heart Failure Point of Care (POC) and Lab on a Chip (LOC) Devices Market is the heightened global awareness surrounding heart failure.
Heart failure is becoming more prevalent, largely due to factors like aging populations, sedentary lifestyles, and the increasing incidence of risk factors such as obesity and diabetes. This upward trend in heart failure cases has created a pressing need for more effective diagnostics and management tools.
Over the past decade, there has been a significant increase in global awareness campaigns, initiatives, and educational programs aimed at informing the public about heart failure. Health organizations, nonprofits, and healthcare professionals have been instrumental in raising awareness about the condition's symptoms, risk factors, and the importance of early diagnosis and management.
Increased global awareness has led to earlier detection of heart failure in many cases. Patients are becoming more aware of the symptoms and risk factors, prompting them to seek medical attention sooner. This has led to better outcomes and reduced complications.
Healthcare professionals worldwide are also benefiting from heightened awareness. They are increasingly recognizing the importance of timely diagnosis and proactive management. POC and LOC devices have been instrumental in providing healthcare professionals with the tools needed for rapid and accurate diagnostics.
The global awareness surrounding heart failure has been further accelerated by the rapid expansion of telemedicine, particularly during the COVID-19 pandemic. POC and LOC devices can be seamlessly integrated into telemedicine platforms, facilitating remote consultations, and monitoring for heart failure patients, even in remote or underserved regions.
Heart failure is not limited by geographic boundaries. It affects people from diverse backgrounds and regions worldwide. The increased global awareness ensures that patients from various demographic and geographic segments have access to advanced healthcare solutions for heart failure diagnosis and management.
Regulatory authorities have recognized the importance of early diagnosis and proactive management in improving patient outcomes. This supportive regulatory environment encourages manufacturers to invest in research and development for POC and LOC devices.
Key Market Challenges
Accuracy and Reliability
POC and LOC devices need to be highly accurate and reliable, as errors can lead to misdiagnoses or improper management of heart failure. Ensuring consistent accuracy remains a significant challenge, especially for smaller and portable devices.
Regulatory Hurdles
The development and commercialization of POC and LOC devices require regulatory approvals and compliance with stringent quality standards. Achieving regulatory clearance is often a lengthy and complex process, delaying the market entry of innovative devices.
Cost Constraints
Developing POC and LOC devices with the necessary accuracy and features can be costly. Reducing the production costs while maintaining quality is a persistent challenge, especially for startups and smaller manufacturers.
Key Market Trends
Integration of Artificial Intelligence (AI)
Artificial intelligence is increasingly being incorporated into POC and LOC devices. AI can enhance diagnostic accuracy, personalize treatment plans, and provide predictive analytics to identify potential heart failure exacerbations before they occur.
Miniaturization and Portability
POC and LOC devices are becoming smaller and more portable, allowing for ease of use at home and in remote settings. This trend is making heart failure management more accessible and convenient for patients.
Multi-Parameter Monitoring
Emerging devices can monitor multiple parameters simultaneously, such as blood pressure, oxygen saturation, and various biomarkers. This comprehensive data collection enables a more holistic understanding of the patient's condition.
Segmental Insights
Test Type Insights
Based on the category of Test Type, the segment focusing on proteomic testing was responsible for the largest portion of revenue in 2022. Advances in omics research have promoted the investigation of genomics, proteomics, and metabolomics in relation to cardiovascular events. This research aids in the identification of new biomarkers and tests for predicting the risk of a heart attack before any symptoms emerge. As an example, in April 2022, scientists at SomaLogic Inc. launched a blood test capable of forecasting an individual's risk of heart attack, stroke, heart failure, and mortality from these conditions over the next four years.
The metabolomics testing sector is projected to experience the highest CAGR during the forecast period. Common peptides like N-terminal pro-B-type natriuretic peptide (NTproBNP), troponin, and B-type natriuretic peptide (BNP) are routinely evaluated to monitor cardiovascular events. Specifically, Troponin T (TnT) and Troponin I (TnI) are the most precise protein biomarkers associated with myocardial infarction.
As a result, many companies have focused on this biomarker as a primary source of revenue. The availability of a relatively large number of commercial point-of-care (POC) devices for protein marker testing has contributed to the estimated market share of proteomic testing.
Technology Insights
The microfluidics sector secured the most substantial portion of revenue in 2022 and is poised to experience the swiftest CAGR in the projected period. There is a heightened concern about mortality and morbidity rates stemming from cardiovascular diseases (CVD), which has spurred a demand for prompt, portable, and cost-effective biosensing devices designed for cardiovascular event screening. Point-of-care (POC) biosensors play a pivotal role in the early detection of heart failure, eliminating the necessity for hospital visits and the associated laborious and expensive laboratory tests.
In recent years, the adoption of microfluidic biosensors has been on the rise, as they enable the integration and miniaturization of functional protocols typically carried out in centralized laboratories onto a portable chip. Additionally, they offer multiple advantages, including reduced consumption of reagents and samples, as well as rapid turnaround times.
Consequently, over the past few years, there has been a significant uptick in the utilization of paper-based 3D microfluidics in POC applications due to their effectiveness in manipulating liquids at a high level. These factors have contributed to the dominant revenue share of microfluidic technology. Anticipated advancements in this technology are expected to propel the segment in the years ahead.
Regional Insights
- In2022, North America took the lead in the market, securing the largest portionof revenue. This was primarily driven by prominent market players in the UnitedStates, contributing significantly to the organic revenue growth in the globalheart failure point-of-care (POC) and lab-on-a-chip (LOC) devices market. Forinstance, in December 2021, Quidel Corporation and Ortho Clinical DiagnosticsHoldings plc entered into a business combination agreement. This agreement hasled to enhanced patient access to a wide range of diagnostic products, includingimmunohematology, immunoassay, molecular diagnostics, clinical chemistry, donorscreening, and point-of-care diagnostics.
- Onthe other hand, there continues to be a rising demand for diagnostic servicesin Asian countries. As we look ahead to the forecast period from 2023 to 2030,the Asia Pacific region is projected to experience the most rapid CAGR. Thisgrowth can be attributed to a shift in emphasis from infectious diseases tochronic conditions such as acute coronary syndrome, myocardial infarction, andcardiac ischemia. Moreover, the increasing standards of medical practice andthe development of state-of-the-art healthcare infrastructure have made Asiancountries an attractive choice for numerous global diagnostic companies lookingto expand their business operations.
Recent Developments
- InDecember 2022, Ultromics' EchoGo received approval from the US Food and DrugAdministration for their EchoGo device, an AI-driven technology that offersprecise heart failure detection in cases with preserved ejection fraction. InMay 2022, BioMérieux completed the acquisition of Specific Diagnostic,bolstering its global leadership in clinical microbiology. This strategic movebrought significant innovation to the market and reinforced the company'sefforts to combat antimicrobial resistance.
- Likewise,in October 2020, Abbott introduced implantable cardioverter defibrillator andcardiac resynchronization therapy defibrillator devices in the Indian market.These devices leverage smartphone connectivity and applications, introducingfresh opportunities for patient engagement and remote monitoring.
Key Market Players
- AbbottLaboratories Inc
- Siemens Healthineers AG
- Danaher Corp
- Instrumentation Laboratory Co
- F Hoffmann-La Roche AG
- bioMérieux S.A.
- Abaxis Inc
- Quidel Corp
- Jant Pharmacal Corp
- Trinity Biotech plc
| By Test Type | By Technology | By End Use | By Region |
|
|
|
|
FAQ'S
For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:
Within 24 to 48 hrs.
You can contact Sales team (sales@marketinsightsresearch.com) and they will direct you on email
You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.
Discounts are available.
Hard Copy